A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex ...

The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...

Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...

Many serious conditions start with symptoms that appear harmless, making it crucial to pay attention to your body's signals.

Lisa Miller interviewed more than two dozen people about the effects weight-loss drugs have had on their romantic ...

Dementia and mild cognitive impairment (MCI) are major concerns for seniors, especially those over 65. About 10% of the US ...

On Thursday, the Food and Drug Administration approved the non-opioid pain relievers from Vertex Pharmaceuticals, a new ...

For centuries, people have claimed that their aching joints can predict changes in the weather, often reporting ...